PCDH8, or Protocadherin 8, belongs to the protocadherin family of cell adhesion molecules and is primarily expressed in the nervous system. Protocadherins are known to play essential roles in mediating cell-cell adhesion and regulating processes such as neuronal development, synapse formation, and axonal guidance. PCDH8 inhibitors are designed to interact with the active site or binding domain of the PCDH8 protein, effectively inhibiting its function in cell adhesion and potentially influencing cellular processes dependent on PCDH8-mediated interactions.
Structurally, PCDH8 inhibitors target the active site of PCDH8, ensuring their specificity for this particular cell adhesion molecule. By inhibiting PCDH8, these compounds may disrupt the normal cell-cell adhesion patterns, which can have implications for processes like neuronal connectivity and circuit formation. The study of PCDH8 inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions in the nervous system. This knowledge contributes to our understanding of basic neurobiology and may have implications in various research areas, including neurodevelopment, synaptic plasticity, and neuronal connectivity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt processing and secretion by inhibiting Porcupine, indirectly affecting PCDH8. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, alters cell signaling pathways potentially influencing PCDH8 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, affects MAPK/ERK pathway, which might indirectly modulate PCDH8. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, may impact signaling pathways indirectly influencing PCDH8 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially affecting pathways related to PCDH8. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, affects cell growth and survival pathways, potentially influencing PCDH8. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
γ-Secretase inhibitor, could indirectly affect PCDH8 by modulating Notch signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, potentially affects cytoskeletal dynamics related to PCDH8. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
V-ATPase inhibitor, can affect endosomal-lysosomal pathways, indirectly impacting PCDH8. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
Disrupts microtubule dynamics, potentially affecting cellular processes related to PCDH8. | ||||||